Compare Cassava Sciences Inc (FLNA) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs iShares Semiconductor ETF — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while iShares Semiconductor ETF trades at $533.82. The key difference: iShares Semiconductor ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | SOXX | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.64 | $655.01 |
52-Week Low | $1.09 | $236.93 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Filana Therapeutics (FLNA) trades at $1.09, down 5.22% on the day, reflecting persistent operational losses despite recent earnings beats. The stock exhibits a strong bearish technical signal, with moving averages and oscillators aligned negatively. Fundamentally, the company is in a pre-revenue biotech development phase, evidenced by significant negative cash flow from operations (-$32.25M in 2025) and deeply negative profitability metrics (ROE: -79.59%). Recent news highlights continued focus on its Tuberous Sclerosis Complex (TSC)-related epilepsy program.
The outlook is bifurcated: a bullish analyst consensus (8 Buy, 4 Hold, 0 Sell) suggests optimism for the clinical pipeline, while severe financial burn and bearish technicals present substantial near-term risk. Investment opportunity hinges entirely on successful drug development, with significant dilution or financing risk as the company funds operations. The stock is suitable only for high-risk investors comfortable with binary clinical outcomes.
SOXX (iShares Semiconductor ETF) trades at $538.09, down 5.25% amid a semiconductor sector pullback after a strong 88.78% YTD gain. Technical indicators show bearish momentum with support at $511 and resistance at $554. The ETF provides concentrated exposure to 30 leading chipmakers, benefiting from AI-driven demand growth but facing cyclical volatility. Recent news highlights Michael Burry's short position and Bank of America labeling semiconductors as the 'most crowded trade ever' (The Motley Fool, 2026-07-16; 24/7 Wall Street, 2026-07-15).
Outlook: Near-term pressure from sector rotation and valuation concerns balances long-term AI growth potential. Risks include cyclical downturns, crowded positioning, and geopolitical tensions. The ETF remains a high-beta play on semiconductor innovation, suitable for investors tolerant of volatility seeking tech exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
